Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
Status:
Completed
Trial end date:
2018-05-18
Target enrollment:
Participant gender:
Summary
This is a one month pre post intervention study. Subjects with diabetic macular edema were
given intravitreal anti VEGF (Aflibercept) injection. Central retinal thickness, macular
electrophysiology, and visual acuity were observed one week and one month after injection was
given to the eye to describe early anatomical, physiological, and clinical changes. We
hypothesized that changes to these outcomes can be found and documented.